Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 Dec;70(6):1165–1170. doi: 10.1038/bjc.1994.466

Changes in use of breast-conserving therapy in years 1978-2000.

H J de Koning 1, J A van Dongen 1, P J van der Maas 1
PMCID: PMC2033702  PMID: 7981070

Abstract

The treatment of breast cancer patients has changed rapidly in the past decade, but empirical data at local and national level are scarce. Predicting the consequences of screening for primary treatment is consequently difficult. The aim of this analysis of records on admissions to hospital of women with breast cancer and/or for breast surgery (1975-90) together with a survey of all Dutch radiotherapy departments (1986-88) is to show the change in breast-conserving therapy and other primary treatment before the start of breast cancer screening in The Netherlands. There was a modest increase in breast-conserving therapy after 1981, coinciding with the first publication on its trial, followed by a sharp increase between 1985 and 1990, after the second publication. At the end of that 5 year period, 36% of all women with newly diagnosed invasive breast cancer underwent this type of surgery. Breast-conserving surgery is always followed by radiotherapy, but there has been a clear reduction in post-operative radiation after mastectomy. The percentage of breast-conserving therapy is at present higher in The Netherlands than in the USA. Implementing the Dutch screening programme will result in a maximum increase in breast-conserving therapy at national level of 34%, which stabilises at +21%, or a 50% maximum increase at local level. The number of women treated by mastectomy will ultimately decrease by 9%. Given the rapidity of change towards the use of breast-conserving surgery, which is enhanced by screening, recent information will be needed in predicting capacity and assessing whether screen-detected women are treated adequately.

Full text

PDF
1165

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartelink H., Borger J. H., van Dongen J. A., Peterse J. L. The impact of tumor size and histology on local control after breast-conserving therapy. Radiother Oncol. 1988 Apr;11(4):297–303. doi: 10.1016/0167-8140(88)90200-9. [DOI] [PubMed] [Google Scholar]
  2. Beemsterboer P. M., de Koning H. J., Warmerdam P. G., Boer R., Swart E., Dierks M. L., Robra B. P. Prediction of the effects and costs of breast-cancer screening in Germany. Int J Cancer. 1994 Sep 1;58(5):623–628. doi: 10.1002/ijc.2910580502. [DOI] [PubMed] [Google Scholar]
  3. Boekema A. G., Dornseiffen G., Mulder H. J., de Vos R. A., Kluft-de Haas B. A. De eerste ervaring met mammascreening in de regio Enschede. I. Effectiviteit. Ned Tijdschr Geneeskd. 1992 Sep 5;136(36):1757–1760. [PubMed] [Google Scholar]
  4. Carter R., Glasziou P., van Oortmarssen G., de Koning H., Stevenson C., Salkeld G., Boer R. Cost-effectiveness of mammographic screening in Australia. Aust J Public Health. 1993 Mar;17(1):42–50. doi: 10.1111/j.1753-6405.1993.tb00103.x. [DOI] [PubMed] [Google Scholar]
  5. Chouillet A. M., Bell C. M., Hiscox J. G. Management of breast cancer in southeast England. BMJ. 1994 Jan 15;308(6922):168–171. doi: 10.1136/bmj.308.6922.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Edland R. W. Does adjuvant radiotherapy have a role in the postmastectomy management of patients with operable breast cancer--revisited. Int J Radiat Oncol Biol Phys. 1988 Sep;15(3):519–535. doi: 10.1016/0360-3016(88)90290-8. [DOI] [PubMed] [Google Scholar]
  7. Farrow D. C., Hunt W. C., Samet J. M. Geographic variation in the treatment of localized breast cancer. N Engl J Med. 1992 Apr 23;326(17):1097–1101. doi: 10.1056/NEJM199204233261701. [DOI] [PubMed] [Google Scholar]
  8. Fisher B., Bauer M., Margolese R., Poisson R., Pilch Y., Redmond C., Fisher E., Wolmark N., Deutsch M., Montague E. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med. 1985 Mar 14;312(11):665–673. doi: 10.1056/NEJM198503143121101. [DOI] [PubMed] [Google Scholar]
  9. Harris J. R., Hellman S. Put the "hockey stick" on ice. Int J Radiat Oncol Biol Phys. 1988 Aug;15(2):497–499. doi: 10.1016/s0360-3016(98)90034-7. [DOI] [PubMed] [Google Scholar]
  10. Hooning M. J., van Dongen J. A., Went G. Changing indications for breast conserving therapy: proportion of patients with operable breast cancer suitable for breast conservation. Neth J Surg. 1991 Aug;43(4):102–104. [PubMed] [Google Scholar]
  11. Lazovich D. A., White E., Thomas D. B., Moe R. E. Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA. 1991 Dec 25;266(24):3433–3438. [PubMed] [Google Scholar]
  12. Osteen R. T., Steele G. D., Jr, Menck H. R., Winchester D. P. Regional differences in surgical management of breast cancer. CA Cancer J Clin. 1992 Jan-Feb;42(1):39–43. doi: 10.3322/canjclin.42.1.39. [DOI] [PubMed] [Google Scholar]
  13. Tabàr L., Fagerberg G., Duffy S. W., Day N. E., Gad A., Gröntoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am. 1992 Jan;30(1):187–210. [PubMed] [Google Scholar]
  14. Veronesi U., Luini A., Del Vecchio M., Greco M., Galimberti V., Merson M., Rilke F., Sacchini V., Saccozzi R., Savio T. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med. 1993 Jun 3;328(22):1587–1591. doi: 10.1056/NEJM199306033282202. [DOI] [PubMed] [Google Scholar]
  15. Veronesi U., Saccozzi R., Del Vecchio M., Banfi A., Clemente C., De Lena M., Gallus G., Greco M., Luini A., Marubini E. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med. 1981 Jul 2;305(1):6–11. doi: 10.1056/NEJM198107023050102. [DOI] [PubMed] [Google Scholar]
  16. de Koning H. J., van Ineveld B. M., de Haes J. C., van Oortmarssen G. J., Klijn J. G., van der Maas P. J. Advanced breast cancer and its prevention by screening. Br J Cancer. 1992 Jun;65(6):950–955. doi: 10.1038/bjc.1992.199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. de Koning H. J., van Ineveld B. M., van Oortmarssen G. J., de Haes J. C., Collette H. J., Hendriks J. H., van der Maas P. J. Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer. 1991 Oct 21;49(4):531–537. doi: 10.1002/ijc.2910490410. [DOI] [PubMed] [Google Scholar]
  18. de Koning H. J., van Oortmarssen G. J., van Ineveld B. M., van der Maas P. J. Breast cancer screening: its impact on clinical medicine. Br J Cancer. 1990 Feb;61(2):292–297. doi: 10.1038/bjc.1990.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. van Dongen J. A., Bartelink H., Fentiman I. S., Lerut T., Mignolet F., Olthuis G., van der Schueren E., Sylvester R., Tong D., Winter J. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer. 1992;28A(4-5):801–805. doi: 10.1016/0959-8049(92)90118-l. [DOI] [PubMed] [Google Scholar]
  20. van Oortmarssen G. J., Habbema J. D., Lubbe J. T., van der Maas P. J. A model-based analysis of the HIP project for breast cancer screening. Int J Cancer. 1990 Aug 15;46(2):207–213. doi: 10.1002/ijc.2910460211. [DOI] [PubMed] [Google Scholar]
  21. van Oortmarssen G. J., Habbema J. D., van der Maas P. J., de Koning H. J., Collette H. J., Verbeek A. L., Geerts A. T., Lubbe K. T. A model for breast cancer screening. Cancer. 1990 Oct 1;66(7):1601–1612. doi: 10.1002/1097-0142(19901001)66:7<1601::aid-cncr2820660727>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES